[an error occurred while processing this directive]

Prescribing Information

Prescribing Information

Actor portrayal

Living with type 2 diabetes?

Once a week. Not once a day.

Awiqli® is the world's first once-weekly basal insulin for adults with type 2 diabetes, used along with diet and exercise to help manage blood sugar.

See how Awiqli® may be an option for you

Starting with once-weekly Awiqli® could mean:

One basal insulin injection a week

No daily basal insulin injection to build—Awiqli® is taken once a week, on the same day every week, right from the start.

Improved blood sugar control with Awiqli®

In studies of adults with type 2 diabetes new to insulin, one weekly Awiqli® improved blood sugar control.a Learn more

One day a week to remember Awiqli®

No daily basal insulin shot to fit into your life.

a52-week study in 984 adult patients with type 2 diabetes new to insulin and not yet controlled on one or more of their current diabetes medications; once-weekly Awiqli® vs insulin glargine U-100. Patients continued their other non-insulin diabetes medications. Certain diabetes medications were discontinued at the start of the study. 26-week study in 588 adult patients with type 2 diabetes new to insulin and not yet controlled on one or more of their current diabetes medications; once-weekly Awiqli® vs insulin degludec U-100. Patients continued their other non-insulin diabetes medications. Certain diabetes medications were reduced at the start of the study.

[an error occurred while processing this directive] [an error occurred while processing this directive] [an error occurred while processing this directive]
[an error occurred while processing this directive]